IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MPM BioImpact LLC

Portfolio Profile

CIK: 0001687078 | BOSTON, MA

Investment Profile

Style

Growth

Turnover

High

Orientation

Concentrated trader
$1.6B
AUM
37
Positions
55.29%
Top 10 Conc.
89.11%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Cullinan Therapeutics, Inc.(CGEM)9,731,341$177.2M10.81%
2Aktis Oncology, Inc.(AKTS)4,835,872$155.9M9.50%
3Liquidia Corporation(LQDA)1,386,174$110.5M6.74%
4Revolution Medicines, Inc.(RVMD)492,483$92.2M5.62%
5Corcept Therapeutics, Inc.(CORT)771,028$67.0M4.09%

Sector Allocation

Latest filing, equity positions only

Healthcare92.85% · $1.5B
Unclassified7.15% · $117.2M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare96.96%92.85%-4.11%
Unclassified3.04%7.15%+4.11%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$374.6M | 32 pos.
$427.4M | 32 pos.
$622.0M | 38 pos.
$643.5M | 44 pos.
$666.6M | 43 pos.
$704.4M | 47 pos.
6
Edgewise Therapeutics Inc(EWTX)
1,620,780
$65.9M
4.02%
7Travere Therapeutics Inc(TVTX)1,122,731$63.8M3.89%
8DBV Technologies S A(DBVT)3,666,284$60.1M3.67%
9Trevi Therapeutics Inc(TRVI)3,073,577$57.3M3.50%
10Alumis Inc(ALMS)2,019,020$56.8M3.46%
Cap SizePrev %Curr %Change
Small Cap53.18%51.32%-1.86%
Mid Cap36.3%34.33%-1.97%
Large Cap5.24%7.16%+1.92%
Unclassified3.04%7.15%+4.11%
Micro Cap2.24%0.05%-2.19%
$581.7M | 43 pos.
$577.2M | 44 pos.
$610.9M | 40 pos.
$874.0M | 38 pos.
$1.3B | 41 pos.
$1.6B | 37 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

7
New
11
Closed
7
Increased
22
Decreased
1
Unchanged